Global Drug-Eluting Stents Market Growth 2023-2029

Global Drug-Eluting Stents Market Growth 2023-2029

A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.

LPI (LP Information)' newest research report, the “Drug-Eluting Stents Industry Forecast” looks at past sales and reviews total world Drug-Eluting Stents sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug-Eluting Stents sales for 2023 through 2029. With Drug-Eluting Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Eluting Stents industry.

This Insight Report provides a comprehensive analysis of the global Drug-Eluting Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Eluting Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug-Eluting Stents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Eluting Stents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Eluting Stents.

The global Drug-Eluting Stents market size is projected to grow from US$ 5824.5 million in 2022 to US$ 7476.2 million in 2029; it is expected to grow at a CAGR of 7476.2 from 2023 to 2029.

North America dominated the global Drug Eluting Stent Market with a revenue share of 37% in 2017. The dominance of the region was majorly attributed to stringent regulatory guidelines for medical device manufacturing and approval. In addition, the reimbursement coverage coupled with a high incidence rate of artery diseases is anticipated to augment the market growth in North America.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Eluting Stents market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Rapamycin
Paclitaxel
Everolimus
Others

Segmentation by application
Angina Pectoris
Myocardial Infarction

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Medtronic, Inc.
Abbott
Lepu Medical
MicroPort Scientific Corporation
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
Liaoning Biomedical Materials R&D Center Co.(LBC)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Drug-Eluting Stents market?

What factors are driving Drug-Eluting Stents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Drug-Eluting Stents market opportunities vary by end market size?

How does Drug-Eluting Stents break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.